封面
市场调查报告书
商品编码
1705958

全球杜普伊特伦挛缩症市场:按疾病类型、按类型和治疗方法、按最终用户、按地区

Global Dupuytrens Disease Market, By Disease Type, By Type and Treatment, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计 2025 年全球杜普伊特伦挛缩症市场规模为 49.8 亿美元,2032 年将达到 69.1 亿美元,2025 年至 2032 年的复合年增长率为 4.8%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 49.8亿美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期:2025-2032年复合年增长率: 4.80% 2032年价值预测 69.1亿美元
数字。 2025 年杜普伊特伦挛缩症的全球市场占有率(按地区划分)
全球杜普伊特伦挛缩症市场-IMG1

杜普伊特伦挛缩症是一种影响掌筋膜(皮肤下的一层纤维组织,覆盖手掌和手指的肌腱、神经、血管和骨骼)的疾病。对于患有杜普伊特伦挛缩症的人来说,筋膜会随着时间的推移而增厚和收缩(缩短)。在此过程中,筋膜可以拉动手指,将其推向手掌内侧。结果,手指很难甚至不可能完全伸直,这种情况称为杜普伊特伦挛缩症。随着杜普伊特伦挛缩症的恶化,它会损害手部功能,使某些人的日常生活变得困难。在这些情况下,可以采用非手术和手术治疗方法来减缓病情的进展(恶化)并改善受影响手指的运动。杜普伊特伦挛缩症的病因尚不清楚。这种疾病往往具有家族遗传性。男性比女性更常见。杜普伊特伦挛缩症多年来逐渐恶化。这种病症始于手掌上出现一个硬块。这个肿块可能会疼痛,也可能不会。随着时间的推移,肿块会变成皮肤下的硬绳并延伸到手指。琴弦紧紧地缠绕着手指,并将它们拉向手掌,有时拉得很猛烈。

市场动态:

预计杜普伊特伦挛缩症盛行率的不断上升将在预测期内推动全球杜普伊特伦挛缩症市场的成长。例如,根据公共关係和赢得媒体软体公司和服务供应商Cision US Inc. 2022 年 10 月发布的数据,估计北美每年有 1,400 万人患有杜普伊特伦挛缩症。

本研究的主要特点

  • 本报告对全球杜普伊特伦挛缩症市场进行了详细分析,并以 2024 年为基准年,展示了预测期(2025-2032 年)的市场规模和復合年增长率。
  • 它还强调了各个领域的潜在收益成长机会,并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 该报告根据公司亮点、产品系列、关键亮点、财务表现和策略等参数,概述了全球杜普伊特伦挛缩症市场的主要企业。
  • 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
  • 全球杜普伊特伦挛缩症市场报告针对该行业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过用于分析全球杜普伊特伦挛缩症市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
  • 杜普伊特伦挛缩症盛行率不断上升
    • 限制因素
  • 治疗费用高
    • 机会
  • 新兴经济体
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

第四章。全球杜普伊特伦挛缩症市场-冠状病毒(COVID-19)大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 2020 年至 2032 年全球杜普伊特伦挛缩症市场(依疾病类型)

  • I型
  • II型
  • III型

第六章 全球杜普伊特伦挛缩症市场(依类型),2020-2032

  • 诊断
  • 身体检查
  • X射线
  • 治疗
  • 外科手术
  • 放射治疗
  • 针腱膜切开术
  • 类固醇注射
  • 酵素注射
  • 职能治疗
  • 其他的

7. 2020 年至 2032 年全球杜普伊特伦挛缩症市场(依最终使用者划分)

  • 医院
  • 诊所
  • 学术研究所
  • 其他的

8. 2020 年至 2032 年全球杜普伊特伦挛缩症市场(按地区)

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东
  • 非洲

第九章竞争格局

  • Endo International Plc
  • Bristol-Meyers Squibb Company
  • Spear Pharmaceuticals
  • GSK Plc.
  • AstraZeneca
  • Hikma Pharmaceuticals Plc
  • LEO Pharma A/S
  • Fresenius Kabi AG
  • Bayer AG
  • Novartis AG
  • Pfizer Inc.
  • Nantong Jinghua Pharmaceutical Co., Ltd.
  • Actiza Pharmaceutical Pvt. Ltd.

第 10 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6530

Global Dupuytrens Disease Market is estimated to be valued at USD 4.98 Bn in 2025 and is expected to reach USD 6.91 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.8% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 4.98 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 4.80% 2032 Value Projection: USD 6.91 Bn
Figure. Global Dupuytrens Disease Market Share (%), By Region 2025
Global Dupuytrens Disease Market - IMG1

Dupuytren's disease is a condition that affects the palmar fascia - the fibrous layer of tissue that lies underneath the skin and above the tendons, nerves, blood vessels, and bones in the palm and fingers. In patients with Dupuytren's disease, the fascia thickens and contracts (shortens) over time. The fascia may pull on the fingers during this process, causing them to be forced inward, toward the palm. This may make it difficult or impossible to fully straighten the fingers, resulting in what is known as a Dupuytren's contracture. In some people, a worsening Dupuytren's contracture can interfere with hand function, making it difficult to perform daily activities. When this occurs, there are non-surgical and surgical treatment options available to help slow the progression (worsening) of the disease and improve motion in the affected fingers. The cause of Dupuytren contracture is unknown. The condition tends to run in families. It is more common in men than in women. Dupuytren contracture gets worse slowly, over years. The condition begins with a firm lump in the palm of the hand. This lump can be painful or painless. Over time, the lump can extend into a hard cord under the skin and up into the finger. This cord tightens and pulls the finger toward the palm, sometimes severely.

Market Dynamics:

The increasing prevalence of Dupuytren's disease is expected to drive the growth of the global Dupuytren's disease market over the forecast period. For instance, according to data published in October 2022 by Cision US Inc., a public relations and earned media software company and services provider, an estimated 14 million people are affected by Dupuytren's disease every year in North America.

Key features of the study:

  • This report provides an in-depth analysis of the global Dupuytren's disease market, and provides market size (US$ Bn ) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global Dupuytren's disease market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Endo International Plc, Bristol-Meyers Squibb Company, Spear Pharmaceuticals, GSK Plc., AstraZeneca, Hikma Pharmaceuticals Plc, LEO Pharma A/S, Fresenius Kabi AG, Bayer AG, Novartis AG, Pfizer Inc., Nantong Jinghua Pharmaceutical Co., Ltd., and Actiza Pharmaceutical Pvt. Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global Dupuytren's disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Dupuytren's disease market

Detailed Segmentation:

  • Global Dupuytren's Disease Market Segmentation, By Disease Type:
    • Type I
    • Type II
    • Type III
  • Global Dupuytren's Disease Market Segmentation, By Type:
    • Diagnosis
    • Physical Examination
    • X-ray
    • Treatment
    • Surgery
    • Radiation Therapy
    • Needle Aponeurotomy
    • Steroid Shot
    • Enzyme Injection
    • Occupational Therapy
    • Others
  • Global Dupuytren's Disease Market Segmentation, By End User:
    • Hospitals
    • Clinics
    • Academic & Research Institute
    • Others
  • Global Dupuytren's Disease Market Segmentation, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profile:
    • Endo International Plc
    • Bristol-Meyers Squibb Company
    • Spear Pharmaceuticals
    • GSK Plc.
    • AstraZeneca
    • Hikma Pharmaceuticals Plc
    • LEO Pharma A/S
    • Fresenius Kabi AG
    • Bayer AG
    • Novartis AG
    • Pfizer Inc.
    • Nantong Jinghua Pharmaceutical Co., Ltd.
    • Actiza Pharmaceutical Pvt. Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Dupuytren's Disease , By Disease Type
    • Market Dupuytren's Disease , By Type
    • Market Dupuytren's Disease , By End User
    • Market Dupuytren's Disease , By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing prevalence of Dupuytren's disease
    • Restraints
  • High cost of treatment
    • Opportunities
  • Emerging economies
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Dupuytren's Disease Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Dupuytren's Disease Market, By Disease Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Type I
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Type II
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Type III
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Dupuytren's Disease Market, By Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Physical Examination
  • X-ray
  • Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Surgery
  • Radiation Therapy
  • Needle Aponeurotomy
  • Steroid Shot
  • Enzyme Injection
  • Occupational Therapy
  • Others

7. Global Dupuytren's Disease Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Academic & Research Institute
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Dupuytren's Disease Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country/Region, Y-o-Y Growth and By Country/Region, 2020 - 2032, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Endo International Plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bristol-Meyers Squibb Company
  • Spear Pharmaceuticals
  • GSK Plc.
  • AstraZeneca
  • Hikma Pharmaceuticals Plc
  • LEO Pharma A/S
  • Fresenius Kabi AG
  • Bayer AG
  • Novartis AG
  • Pfizer Inc.
  • Nantong Jinghua Pharmaceutical Co., Ltd.
  • Actiza Pharmaceutical Pvt. Ltd.
  • Analyst Views

10. Section

  • Research Methodology
  • About us